Email
Password
Remember meForgot password?
    Log in with Twitter

Endo International News

FDA asks pharmaceutical company to pull opioid from drug market

On Thursday, the U.S. Food and Drug Administration (FDA) requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market due to concerns over abuse.
 

Search Digital Journal Archives


Set up a news alert for

Endo International


Endo International Image


Latest News
Top News